Variables | Â | Quartiles of HLS | Â | Â | P-value trend |
---|---|---|---|---|---|
 | Q1(N = 58) | Q2(N = 135) | Q3(N = 109) | Q4(N = 45) |  |
MetS | |||||
 Crude | 1 (Ref.) | 1.29 (0.94–2.66) | 1.19(0.81–2.82) | 0.97(0.71–2.75) | 0.13 |
 Model 1 | 1 (Ref.) | 1.23 (1.04–2.65) | 1.17 (0.76–2.87) | 0.95(0.89–2.75) | 0.01 |
 Model 2 | 1 (Ref.) | 1.24 (1.05–2.66) | 1.18(0.75–2.86) | 0.96(0.86–2.77) | 0.03 |
High WC | |||||
 Crude | 1 (Ref.) | 1.34 (0.57–2.44) | 0.92 (0.19–2.16) | 0.89 (0.69–2.34) | 0.75 |
 Model 1 | 1 (Ref.) | 1.47 (0.54–2.35) | 1.12 (0.22–2.35) | 0.84 (0.89–2.45) | 0.32 |
 Model 2 | 1 (Ref.) | 1.46 (0.53–2.36) | 1.13 (0.93–2.34) | 0.83 (0.88–2.44) | 0.34 |
High TG | |||||
 Crude | 1 (Ref.) | 0.98 (0.68–1.54) | 0.95 (0.69–1.32) | 0.89 (0.54–1.06) | 0.02 |
 Model 1 | 1 (Ref.) | 1.02 (0.72–1.48) | 0.94 (0.66–1.37) | 0.83 (0.55–0.96) |  < 0.01 |
 Model 2 | 1 (Ref.) | 1.030 (0.74–1.47) | 0.93 (0.65–1. 36) | 0.82 (0.54–0.95) |  < 0.01 |
Low HDL-C | |||||
 Crude | 1 (Ref.) | 1.62 (0.29–2.31) | 0.67(0.28–1.58) | 0.50 (0.14–1.77) | 0.58 |
 Model 1 | 1 (Ref.) | 1.58 (0.26–2.29) | 0.78(0.30–2.09) | 0.60 (0.15–2.34) | 0.58 |
 Model 2 | 1 (Ref.) | 1.56 (0.24–2.30) | 0.83 (0.28–2.46) | 0.56 (0.13–2.42) | 0.61 |
Hyperglycemia | |||||
 Crude | 1 (Ref.) | 1.17(0.95–2.94) | 0.98(0.59–1.35) | 0.94(0.42–1.32) | 0.09 |
 Model 1 | 1 (Ref.) | 1.19(1.00–2.54) | 0.85(0.57–133) | 0.87(0.56–0.95) | 0.04 |
 Model 2 | 1 (Ref.) | 1.20(0.68–2.37) | 0.90(0.58–1.38) | 0.85(0.55–0.96) | 0.12 |
Elevated blood pressure | |||||
 Crude | 1 (Ref.) | 0.83 (0.34–2.05) | 1.10(0.41–2.92) | 1.51(0.38–5.96) | 0.54 |
 Model 1 | 1 (Ref.) | 0.76 (0.27–2.10) | 1.08(0.33–3.50) | 1.33(0.29–6.07) | 0.62 |
 Model 2 | 1 (Ref.) | 1.00 (0.34–2.94) | 1.76 (0.45–3.81) | 2.51 (0.47–6.29) | 0.2 |